Myopia, a leading cause of visual impairment globally, can progress to serious complications like retinal and choroidal degeneration. While atropine is commonly used to manage childhood myopia, its nonselective action on all five acetylcholine muscarinic receptor subtypes (M1-M5 receptors) can cause side effects such as pupil dilation and photophobia.